Atlas One · Host Biology · Scale 07 — System

RSV

RSV (pneumovirus; negative-sense ssRNA) is the leading cause of infant bronchiolitis and severe LRTI in elderly/immunocompromised; NS1/NS2 block MAVS/IFN-β; nirsevimab (anti-F mAb) prevents severe infant RSV; mRNA-1345 (Abrysvo) and mResvia approved 2023 for adults 60+.

Also known as: RSV, respiratory syncytial virus, RSV bronchiolitis, infant RSV, nirsevimab, Beyfortus, palivizumab, Synagis, Abrysvo, mResvia, mRNA-1345, RSV-A, RSV-B, RSV pneumonia, pneumovirus, RSV vaccine

Scale 07 — SystemScale
draftStatus
2026-06-08Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
rsv

RSV

RSV (pneumovirus; negative-sense ssRNA) is the leading cause of infant bronchiolitis and severe LRTI in elderly/immunocompromised; NS1/NS2 block MAVS/IFN-β; nirsevimab (anti-F mAb) prevents severe infant RSV; mRNA-1345 (Abrysvo) and mResvia approved 2023 for adults 60+.

Entry Metadata

FieldValue
IDrsv
NameRSV
Statusdraft
Last reviewed2026-06-08
Atlas01-human
Scale07-system

Cross-Atlas Connections

connects-toRsv F Protein connects-toMavs connects-toIl 33 connects-toTslp connects-toType I Interferon connects-toRespiratory Syncytial Virus connects-toLung connects-toAsthma connects-toCovid 19 Disease connects-toCopd connects-toType Ii Pneumocyte

Sources